Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 2 (February)

1. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
   Nat Cell Biol, 9(2): 139-48. [Abstract] [Full-text]
2. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.
   Trends Pharmacol Sci, 28(2): 51-60. [Abstract] [Full-text]
3. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
   Neurobiol Aging, 28(3): 327-35. [Abstract] [Full-text]
4. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
   Neurobiol Aging, 28(3): 357-70. [Abstract] [Full-text]
5. Midlife respiratory function and Incidence of Alzheimer's disease: a 29-year longitudinal study in women.
   Neurobiol Aging, 28(3): 343-50. [Abstract] [Full-text]
6. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease.
   Neurobiol Aging, 28(3): 351-6. [Abstract] [Full-text]
7. Determinants of platelet activation in Alzheimer's disease.
   Neurobiol Aging, 28(3): 336-42. [Abstract] [Full-text]
8. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
   J Neuropathol Exp Neurol, 66(2): 158-67. [Abstract] [Full-text]
9. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
   J Psychiatr Res, 41(5): 387-94. [Abstract] [Full-text]
10. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
    Arch Neurol, 64(2): 266-72. [Abstract] [Full-text]
11. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Neurology, 68(7): 501-8. [Abstract] [Full-text]
12. White matter lesions - age-adjusted values for cognitively healthy and demented subjects.
    Acta Neurol Scand, 115(3): 174-80. [Abstract] [Full-text]
13. Targeting the nerve growth factor network in Alzheimer's disease.
    Expert Opin Investig Drugs, 16(3): 267-9. [Abstract] [Full-text]
14. Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease.
    Hum Pathol, 38(3): 426-34. [Abstract] [Full-text]
15. Alzheimer's disease (AD) with and without white matter pathology-clinical identification of concurrent cardiovascular disorders.
    Arch Gerontol Geriatr, 44(3): 277-86. [Abstract] [Full-text]
16. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
    BMC Genet, 8: 3. [Abstract] [Full-text]
17. Single photon emission computed tomography perfusion differences in mild cognitive impairment.
    J Neurol Neurosurg Psychiatry, 78(3): 240-7. [Abstract] [Full-text]
18. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.
    J Neurol Neurosurg Psychiatry, 78(3): 233-9. [Abstract] [Full-text]
19. C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.
    Life Sci, 80(12): 1152-6. [Abstract] [Full-text]
20. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    J Neurochem, 100(3): 802-9. [Abstract] [Full-text]
21. Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease.
    Neurobiol Aging, 28(4): 485-96. [Abstract] [Full-text]
22. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers.
    Neurobiol Aging, 28(4): 519-23. [Abstract] [Full-text]
23. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
    Neurobiol Aging, 28(4): 533-6. [Abstract] [Full-text]
24. The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment.
    Neurobiol Aging, 28(4): 515-8. [Abstract] [Full-text]
25. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
    J Mol Biol, 367(1): 148-61. [Abstract] [Full-text]
26. Investigation of Alzheimer's disease-related pathology in community dwelling older subjects who committed suicide.
    J Affect Disord, 99(1): 127-32. [Abstract] [Full-text]
27. Variations in the APP gene promoter region and risk of Alzheimer disease.
    Neurology, 68(9): 684-7. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.